epcoritamab
abbvie,genmab
['nhl', 'epcore,nhl,i,(-ii)', 'epcoritamab', 'epcore,nhl,2', 'congrat', 'dlbcl']
epcoritamab+rdhax/c: quickly effective and well tolerated in rrdlbcl in the epcore nhl-2 study #ash22 congratulations for a great presentation dr pau abrisqueta (3rd hit ) 
Hematologist at @hvhebron Lymphoma Unit & Hematological Diagnosis @Hemato_Vhebron and @labclinicsvh Barcelona